Login

Olivia Lum: President of Hyflux, leading water and environmental solutions company based in Singapore. 00:10:00

Share On Facebook Share On Twitter

Olivia Lum is Chairman/CEO at Hyflux Ltd.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Egan Street Resources: Matilda Gold Project Overview
00:10:00
Datasonic is ready to help the government create a special subsidy card equipped with a technological system to support the targeted subsidy mechanism | JENS MONTANANA, CEO, Datasonic Group BhdDSONIC:KLS
00:00:00
Erik Kinnman, CEO, NeuroVive Pharmaceutical
00:10:00
Andy elaborates on Capita's digital transformation approach, directing viewers to their website and LinkedIn page for further information.
00:00:00
Joseph T. Breen, M.D. Otolaryngologist, Mayo Clinic
00:00:00
Cellmid expanding products, portfolio and markets - Maria Halasz , CEO, Cellmid Ltd
00:10:00
New impact VC fund backing startups led by underrepresented professionals|Brian Brackeen,General Partner,Lightship Capital
00:10:00
Victaulic's Pioneering Innovations in Piping Systems
00:10:00
Faraday Copper: Developing Significant U.S. Copper Resources
00:10:00
Sohn Kyung Shik of the CJ Group on China, North Korea, and the Trade War | Sin ho Kang, CEO, CJ Corp104:KSC
00:10:00
Mats Karlsson Landré and I discuss data diodes and OT. | Marie Bengtsson, CEO, Advenica AB (publ) ADVE:STO
00:10:00
"Insights from an Investing Guru on Avoiding Financials, Index Funds, and the Risks to Apple's Profit Margin"

© 2017 - Neuhu+